Evidence map›Paper›PMID 30805954›Full record

ArticleArtificial organs2019

Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.

Zengsheng Chen, Jiafeng Zhang, Kafayat Kareem, Douglas Tran, Robert G Conway, Katherin Arias, Bartley P Griffith, Zhongjun J Wu

Open access · greenAbstract read
In one paragraph

Article in Artificial organs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zengsheng ChenDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Jiafeng ZhangDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Kafayat KareemDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Douglas TranDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Robert G ConwayDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Katherin AriasDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Bartley P GriffithDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Zhongjun J WuDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-0807-7195
University of Maryland, Baltimore · US

Funding

Supplement: Hemolysis Prediction Software DevelopmentR01HL131750 · NHLBI · LEHIGH UNIVERSITY · PI LIU, YALING · 2017 to 2021
$2.2M
Shear-Induced Hemostatic Dysfunction and Bleeding in CF-VAD PatientsR01HL124170 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI GRIFFITH, BARTLEY P, WU, ZHONGJUN JON · 2015 to 2018
$2.0M
NHLBI NIH HHS R01 HL124170NHLBI NIH HHS R01HL124170NHLBI NIH HHS R01 HL131750NHLBI NIH HHS R01HL131750
6 · The paper itself

Abstract

Thrombotic and bleeding complications are the major obstacles for expanding mechanical circulatory support (MCS) beyond the current use. While providing the needed hemodynamic support, those devices can induce damage to blood, particularly to platelets. In this study, we investigated device-induced alteration of three major platelet surface receptors, von Willebrand factor (VWF) and associated hemostatic functions relevant to thrombosis and bleeding. Fresh human whole blood was circulated in an extracorporeal circuit with a clinical rotary blood pump (CentriMag, Abbott, Chicago, IL, USA) under the clinically relevant operating condition for 4 hours. Blood samples were examined every hour for glycoprotein (GP) IIb/IIIa activation and receptor loss of GPVI and GPIbα on the platelet surface with flow cytometry. Soluble P-selectin in hourly collected blood samples was measured by enzyme linked immunosorbent assay to characterize platelet activation. Adhesion of device-injured platelets to fibrinogen, collagen, and VWF was quantified with fluorescent microscopy. Device-induced damage to VWF was characterized with western blotting. The CentriMag blood pump induced progressive platelet activation with blood circulating time. Particularly, GPIIb/IIIa activation increased from 1.1% (Base) to 11% (4 hours) and soluble P-selectin concentration increased from 14.1 ng/mL (Base) to 26.5 ng/mL (4 hours). Those device-activated platelets exhibited increased adhesion capacity to fibrinogen. Concurrently, the CentriMag blood pump caused progressive platelet receptor loss (GPVI and GPIbα) with blood circulating time. Specifically, MFI of the GPVI and GPIbα receptors decreased by 17.2% and 16.1% for the 4-hours sample compared to the baseline samples, respectively. The device-injured platelets exhibited reduced adhesion capacities to collagen and VWF. The high molecular weight multimers (HMWM) of VWF in the blood disappeared within the first hour of the circulation. Thereafter the multimeric patterns of VWF were stable. The change in the VWF multimeric pattern was different from the progressive structural and functional changes of platelets with the circulation time. This study suggested that the CentriMag blood pump could induce two opposite effects on platelets and associated hemostatic functions under a clinically relevant operating condition. The device-altered hemostatic function may contribute to thrombosis and bleeding simultaneously as occurring in patients supported by a rotary blood pump. Device-induced damage of platelets may be an important cause for bleeding in patients supported with rotary blood pump MCS systems relative to device-induced loss of HMWM-VWF.

Indexed as

Platelet ActivationBlood PlateletsEquipment DesignHeart-Assist DevicesHemorrhageHumansPlatelet AdhesivenessPlatelet Membrane GlycoproteinsThrombosisvon Willebrand FactorPlatelet Membrane Glycoproteinsplatelet membrane glycoprotein VIvon Willebrand Factorcontinuous flow ventricular assist devicehemostasis dysfunctionhigh mechanical shear stressplateletvon Willebrand factor

Identifiers

PMID30805954
PMCPMC6687529
OpenAlexW2915181081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.